MELVILLE, N.Y.--(BUSINESS WIRE)--March 7, 2006--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today its financial results for the Company’s year ended December 31, 2005. The Company reported a net loss of $157.1 million (or $3.02 per share) for fiscal 2005 compared with $268.6 million (or $6.36 per share) for the 12 month period ending December 31, 2004. The 2005 results reflect the operations of Eyetech Pharmaceuticals, Inc. for the period November 14, 2005 through December 31, 2005. On an adjusted basis, the Company’s net loss was $77.1 million (or $1.48 per share) for 2005 compared to the net loss of $188 million (or $4.45 per share) for 2004. Adjusted net loss and adjusted loss per share excludes purchase accounting adjustments, merger-related costs, and certain other significant items. In 2004, the Company changed its fiscal year end from September 30 to December 31.
